Published in Cancer Immunol Immunother on June 01, 1995
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood (2010) 2.41
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med (2014) 1.59
A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice. Proc Natl Acad Sci U S A (1997) 0.79
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost (2009) 4.95
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med (1995) 4.32
Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost (2007) 2.86
The enzymatic phosphorylation of ribonucleic acid and deoxyribonucleic acid. I. Phosphorylation at 5'-hydroxyl termini. J Biol Chem (1966) 2.36
Membrane site modified on induction of the transformation of lymphocytes by periodate. Proc Natl Acad Sci U S A (1972) 2.22
Induction of lymphocyte transformation by sequential treatment with neuraminidase and galactose oxidase. Proc Natl Acad Sci U S A (1973) 2.01
Lymphocyte transformation induced by concanavalin A and its reversion by methyl-alpha-D-mannopyranoside. Biochim Biophys Acta (1971) 1.98
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
gamma-Glutamyl transpeptidase, a lymphoid cell-surface marker: relationship to blastogenesis, differentiation, and neoplasia. Proc Natl Acad Sci U S A (1976) 1.78
The enzymatic phosphorylation of ribonucleic acid and deoxyribonucleic acid. II. Further properties of the 5'-hydroxyl polynucleotide kinase. J Biol Chem (1966) 1.73
Effect of phytohemagglutinin and prostaglandins on cyclic AMP synthesis in rat lymph node lymphocytes. Biochim Biophys Acta (1970) 1.67
p21ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem (1995) 1.67
Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost (1993) 1.65
Disseminated human herpesvirus 6 infection in AIDS. Lancet (1993) 1.64
Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients. J Viral Hepat (2009) 1.62
Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J Biol Chem (1995) 1.61
Peanut agglutinin, a new mitogen that binds to galactosyl sites exposed after neuraminidase treatment. J Immunol (1975) 1.58
Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin Exp Immunol (1985) 1.57
Epidemiology of post-infarction risk stratification strategies in a country with a low volume of revascularization procedures. GISSI-Prognosis Investigators. Eur Heart J (1998) 1.56
Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost (1991) 1.55
Ischaemic brain lesions diagnosed at birth in preterm infants: clinical events and developmental outcome. Arch Dis Child (1990) 1.54
Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol (1993) 1.53
Accuracy and reliability of frozen section diagnosis in a series of 672 nonpalpable breast lesions. Am J Clin Pathol (1995) 1.51
High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1--associated predominantly sensory polyneuropathy. J Infect Dis (1995) 1.47
Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol (1996) 1.45
Translocation of glutathione from lymphoid cells that have markedly different gamma-glutamyl transpeptidase activities. Proc Natl Acad Sci U S A (1979) 1.43
Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev (1994) 1.42
Thallium-201 reverse redistribution at reinjection imaging correlated with coronary lesion, wall motion abnormality and tissue viability. J Nucl Med (1996) 1.41
Increased levels of beta 2-glycoprotein I (aca-Cofactor) in patients with lupus anticoagulant. Thromb Haemost (1992) 1.39
Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet (1990) 1.38
Fast geodesic active contours. IEEE Trans Image Process (2001) 1.38
Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol (1986) 1.37
Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc Natl Acad Sci U S A (1982) 1.36
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS (1999) 1.36
Terrestrial gamma-ray flashes as powerful particle accelerators. Phys Rev Lett (2011) 1.35
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32
Effect of macrophages on periodate-induced transformation of normal and chronic lymphatic leukaemia lymphocytes. Clin Exp Immunol (1974) 1.30
Use of the normalcy index for the evaluation of gait pathology. Gait Posture (2004) 1.28
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood (1996) 1.23
Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. J Immunol (1984) 1.20
Inhibition of amino acid transport into lymphoid cells by the glutamine analog L-2-amino-4-oxo-5-chloropentanoate. Proc Natl Acad Sci U S A (1979) 1.20
Selective activation of mouse T and B lymphocytes by periodate, galactose oxidase and soybean agglutinin. Eur J Immunol (1974) 1.19
Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. Biochemistry (1996) 1.19
Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase. J Exp Med (1980) 1.18
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18
Biomechanical analysis of sit-to-stand movement in normal and obese subjects. Clin Biomech (Bristol, Avon) (2003) 1.17
Enhancement of mouse thymus cells response to periodate treatment by a soluble factor. J Immunol (1972) 1.17
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors. Antimicrob Agents Chemother (2000) 1.17
Reproductive history and gastric cancer among post-menopausal women. Int J Cancer (1994) 1.16
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Antivir Ther (2000) 1.16
Selective suppression by adherent cells, prostaglandin, and cyclic AMP analogues of blastogenesis induced by different mitogens. J Immunol (1979) 1.14
Nitric oxide signaling: a possible role for G proteins. J Immunol (1993) 1.14
Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res (1995) 1.13
Discovery of powerful gamma-ray flares from the Crab Nebula. Science (2011) 1.13
Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica (1997) 1.12
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure. Antivir Ther (1998) 1.10
Galactose oxidase-induced blastogenesis of human lymphocytes and the effect of macrophages on the reaction. Clin Exp Immunol (1975) 1.09
Hydroxyl radical scavengers inhibit human natural killer cell activity. Nature (1984) 1.08
Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer (1983) 1.08
Lymphocyte mitogenesis induced by a mammalian liver protein that specifically binds desialylated glycoproteins. Proc Natl Acad Sci U S A (1977) 1.08
A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol (1996) 1.06
Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood (2001) 1.05
Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. AIDS Res Hum Retroviruses (1996) 1.05
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades. HIV Med (2010) 1.05
Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum. J Infect (2000) 1.04
Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood (1997) 1.04
Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol (2001) 1.04
Transformation of neuraminidase-treated lymphocytes by soybean agglutinin. Proc Natl Acad Sci U S A (1973) 1.03
Functional dissection of the cis-acting sequences of the Arabidopsis transposable element Tag1 reveals dissimilar subterminal sequence and minimal spacing requirements for transposition. Genetics (2001) 1.02
AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy. HIV Med (2009) 1.02
Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. J Infect Dis (1997) 0.99
Chemokine production in HIV-seropositive long-term asymptomatic individuals. AIDS (1996) 0.99
Children conceived by in vitro fertilisation after fresh embryo transfer. Arch Dis Child Fetal Neonatal Ed (1997) 0.99
Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science (1997) 0.99
A chemical approach for the localization of membrane sites involved in lymphocyte activation. Biochem Biophys Res Commun (1976) 0.99
Reproducibility of histological diagnosis of breast lesions: results of a panel in Italy. Eur J Cancer (1996) 0.98
Quantum confinement and electroluminescence in ultrathin silicon nanowires fabricated by a maskless etching technique. Nanotechnology (2012) 0.98
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses (1996) 0.97
Disseminated Rhodococcus equi infection initially presenting as foot mycetoma in an HIV-positive patient. AIDS (1992) 0.97
New aspects of glutathione metabolism and translocation in mammals. Ciba Found Symp (1979) 0.97
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood (1994) 0.97
HCV and non-Hodgkin lymphoma. Lancet (1996) 0.96
Selective effects of TPA and IL-1 on protein phosphorylation in murine thymocytes. Cell Immunol (1985) 0.96
Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. Biochem Cell Biol (1989) 0.96
Transglutaminase activity in human lymphocytes: early activation by phytomitogens. Proc Natl Acad Sci U S A (1978) 0.96
Inosiplex in recurrent herpes simplex infections. Lancet (1982) 0.95
Stimulation of human peripheral blood lymphocytes by periodate, galactose oxidase, soybean agglutinin, and peanut agglutinin: differential effects of adherent cells. J Immunol (1977) 0.94
Lymphocyte commitment to DNA replication induced by concanavalin A. Exp Cell Res (1978) 0.93
Enhanced 1.54 μm emission in Y-Er disilicate thin films on silicon photonic crystal cavities. Opt Express (2013) 0.93
Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol (1983) 0.93
HIV-1 infection, tuberculosis, and syphilis in male transsexual prostitutes in Milan, Italy. J Acquir Immune Defic Syndr (1991) 0.93
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig Liver Dis (2007) 0.93
CD4 cell counts at the third month of HAART may predict clinical failure. AIDS (1999) 0.93
Extreme particle acceleration in the microquasar Cygnus X-3. Nature (2009) 0.93
Cofactors involved in the antiphospholipid syndrome. Lupus (1992) 0.92
Rapid spread of HIV infection in a rural district in central Africa. AIDS (1988) 0.92
Absence of HHV-8 in prostate and semen. N Engl J Med (1996) 0.92
The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). Clin Infect Dis (1996) 0.92